Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00886262 · ClinicalTrials.gov registry record · NA
Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00886262 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 18 participants.
The verdict
NCT00886262, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is evaluate the medication vasopressin for its ability to preserve kidney function in patients undergoing liver transplantation.
Interventions
- DRUG Vasopressin
- DRUG Normal saline placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00886262
The ClinicalTrials.gov registry entry for NCT00886262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vasopressin is the first listed.
NCT00886262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00886262 about?
NCT00886262 is a clinical study titled "Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant". The purpose of this study is evaluate the medication vasopressin for its ability to preserve kidney function in patients undergoing liver transplantation.
What is the current status of trial NCT00886262?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2007-07. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00886262?
The interventions under investigation include: Vasopressin (DRUG), Normal saline placebo (DRUG).
Who is sponsoring clinical trial NCT00886262?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.